BG Medicine Story Overview

BGMD -- USA Stock  

USD 0.029  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for BG Medicine. But even though we do not provide professional-grade financial sentiment analysis on BG Medicine, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for BG Medicine. Check also Trending Equities.
Acquisition by Stelios Papadopoulos of 4205 shares of BG Medicine subject to Rule 16b-3
Filed transaction by Bg Medicine Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

BG Medicine Inc insider trading alert for grant of stock option (right to buy) by Stelios Papadopoulos, the corporate stakeholder, on January 3, 2018. This event was filed by Bg Medicine Inc with SEC on 2013-06-14. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 25.00% . The overall trading delta when the story was published against the current closing price is 27.50% .

Similar stores for BG Medicine

2 days ago at www.macroaxis.com 
Exercise of in-the-money or at-the-money derivative position by Noubar Afeyan of 1724 shares of BG Medicine
Macroaxis News
Filed transaction by Bg Medicine Inc director. Derivative codes exercise of in-the-money or at-the-money derivative security
few days ago at http://www.bgdailynews.com 
BC-MCT-NEWS-BJT
news
Bowling Green Daily NewsFull coverage
over three weeks ago at http://markets.businessinsider.com 
Cardiac Biomarkers Market Report 2018 - Global Strategic Business Analysis covering 2016-2024
businessinsider News
Markets InsiderFull coverage
over a month ago at http://cardinalweekly.com 
Retirement Systems Of Alabama Raised Incyte Stake Kelly Lawrence W Associates Increased BG Foods ...
news
The Cardinal Weekly Full coverage
over a month ago at http://xnewspress.com 
Hercules Capital Inc Expected to Post Quarterly Sales of 54.32 Million
news
XNewsPressFull coverage
over a month ago at www.macroaxis.com 
Exercise of in-the-money or at-the-money derivative position by Noubar Afeyan of 7001 shares of BG Medicine
Macroaxis News
Filed transaction by Bg Medicine Inc director. Derivative codes exercise of in-the-money or at-the-money derivative security
over a month ago at http://www.fairfieldcurrent.com 
Brokerages Set RingCentral Inc PT at 86.46
news
Fairfield CurrentFull coverage
over a month ago at www.macroaxis.com 
Sale by Stelios Papadopoulos of tradable shares of BG Medicine
Macroaxis News
Filed transaction by Bg Medicine Inc director. General open market or private sale of non-derivative or derivative security
over a month ago at www.macroaxis.com 
Acquisition by Stelios Papadopoulos of 4205 shares of BG Medicine subject to Rule 16b-3
Macroaxis News
Filed transaction by Bg Medicine Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over two months ago at http://www.fairfieldcurrent.com 
Kirsten A. Hink Sells 8486 Shares of Sanchez Energy Corp Stock
news
Fairfield CurrentFull coverage
over two months ago at http://www.fairfieldcurrent.com 
Comcast Co. is Ironvine Capital Partners LLCs 10th Largest Position
news
Fairfield CurrentFull coverage
over six months ago at http://stocknewstimes.com 
Analyzing BG Medicine and Encompass Health
news
StockNewsTimesFull coverage
over six months ago at www.macroaxis.com 
BG Medicine exotic insider transaction detected
Macroaxis News
Filed transaction by Bg Medicine Inc director. Unconventional Insider trading
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Current Ratio

Current Ratio Comparative Analysis

  Current Ratio 
      BG Medicine Comparables 
BG Medicine is currently under evaluation in current ratio category among related companies. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Check also Trending Equities. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Search macroaxis.com